LEADER 01687nmm a2200337 u 4500
001 EB001888646
003 EBX01000000000000001052007
005 00000000000000.0
007 cr|||||||||||||||||||||
008 200106 ||| eng
100 1 |a Awad, Mark M. 
245 0 0 |a Immunotherapy in lung cancer  |h Elektronische Ressource  |c Mark M. Awad 
260 |a London  |b Henry Stewart Talks  |c 2019, 2019 
300 |a 1 streaming video file (37 min.)  |b color, sound 
505 0 |a Changing treatment paradigm for stage IV non-small cell lung cancer -- Immunotherapy after chemoradiation in unresectable stage III lung cancer -- Investigating immune checkpoint inhibition in early-stage surgically-resectable lung cancer -- Immunotherapy for small cell lung cancer -- Biomarkers of response to immunotherapy in lung cancer 
653 |a Carcinoma, Non-Small-Cell Lung / therapy 
653 |a Carcinoma, Non-Small-Cell Lung / immunology 
653 |a Immunotherapy 
653 |a Lung Neoplasms / immunology 
653 |a Small Cell Lung Carcinoma / therapy 
653 |a Small Cell Lung Carcinoma / immunology 
653 |a Lungs / Cancer / Immunological aspects 
653 |a Lungs / Cancer / Treatment 
653 |a Lung Neoplasms / therapy 
041 0 7 |a eng  |2 ISO 639-2 
989 |b HST  |a Henry Stewart Talks 
490 0 |a Periodic reports : advances in clinical interventions and research platforms 
500 |a Animated audio-visual presentation with synchronized narration. - Title from title frames. - Mode of access: World Wide Web 
856 4 0 |u https://hstalks.com/bs/4100  |x Verlag  |z Streaming video file 
856 4 2 |u https://hstalks.com/bs/p/1048  |3 Series 
082 0 |a 570